BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 21357630)

  • 1. Pharmacologic inhibition of the renin-angiotensin system did not attenuate hepatic toxicity induced by carbon tetrachloride in rats.
    Ekor M; Odewabi AO; Kale OE; Oritogun KS; Adesanoye OA; Bamidele TO
    Hum Exp Toxicol; 2011 Nov; 30(11):1840-8. PubMed ID: 21357630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression of AT1 receptor on hepatic stellate cells in rat fibrosis induced by CCl4.
    Wei H; Lu H; Li D; Zhan Y; Wang Z; Huang X
    Chin Med J (Engl); 2001 Jun; 114(6):583-7. PubMed ID: 11780431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renin-Angiotensin-Aldosterone Signaling Inhibitors-Losartan, Enalapril, and Cardosten-Prevent Infarction-induced Heart Failure Development in Rats.
    Kiss K; Fekete V; Pálóczi J; Sárközy M; Murlasits Z; Pipis J; Kheyfets IA; Dugina JL; Sergeeva SA; Epstein OI; Csonka C; Csont T; Ferdinandy P; Bencsik P
    Altern Ther Health Med; 2016; 22(2):10-7. PubMed ID: 27036051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the renin-angiotensin system attenuates the development of liver fibrosis and oxidative stress in rats.
    El-Demerdash E; Salam OM; El-Batran SA; Abdallah HM; Shaffie NM
    Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):159-67. PubMed ID: 17900296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Both enalapril and losartan attenuate sarcolemmal Na+-K+-ATPase remodeling in failing rat heart due to myocardial infarction.
    Guo X; Wang J; Elimban V; Dhalla NS
    Can J Physiol Pharmacol; 2008 Apr; 86(4):139-47. PubMed ID: 18418421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antioxidant activity of the oyster mushroom, Pleurotus ostreatus, on CCl(4)-induced liver injury in rats.
    Jayakumar T; Ramesh E; Geraldine P
    Food Chem Toxicol; 2006 Dec; 44(12):1989-96. PubMed ID: 16914248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of losartan, an angiotensin II antagonist, on hepatic fibrosis induced by CCl4 in rats.
    Wei YH; Jun L; Qiang CJ
    Dig Dis Sci; 2004 Oct; 49(10):1589-94. PubMed ID: 15573910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of enalapril and losartan on mechanical ventilation-induced sympathoadrenal activation and oxidative stress in rats.
    Toklu HZ; Kwon OS; Sakarya Y; Powers SK; Llinas K; Kirichenko N; Sollanek KJ; Wiggs MP; Smuder AJ; Talbert EE; Scarpace PJ; Tümer N
    J Surg Res; 2014 May; 188(2):510-6. PubMed ID: 24630519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose angiotensin II receptor antagonists and angiotensin II-converting enzyme inhibitors alone or in combination for treatment of primary glomerulonephritis.
    Renke M; Tylicki L; Rutkowski P; Rutkowski B
    Scand J Urol Nephrol; 2004; 38(5):427-33. PubMed ID: 15764256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II inhibition attenuates postexercise proteinuria in rats.
    Gündüz F; Kuru O; Sentürk UK
    Int J Sports Med; 2005 Nov; 26(9):710-3. PubMed ID: 16237614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of the angiotensin II receptor, type 1 receptor antagonists, losartan and telmisartan, on thioacetamide-induced liver fibrosis in rats.
    Czechowska G; Celinski K; Korolczuk A; Wojcicka G; Dudka J; Bojarska A; Madro A; Brzozowski T
    J Physiol Pharmacol; 2016 Aug; 67(4):575-586. PubMed ID: 27779478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.
    Erman A; Veksler S; Gafter U; Boner G; Wittenberg C; van Dijk DJ
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):146-51. PubMed ID: 15526251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic morphological alterations, glycogen content and cytochrome P450 activities in rats treated chronically with N(omega)-nitro-L-arginine methyl ester (L-NAME).
    Tarsitano CA; Paffaro VA; Pauli JR; da Silva GH; Saad MJ; Salgado I; da Cruz-Höfling MA; Hyslop S
    Cell Tissue Res; 2007 Jul; 329(1):45-58. PubMed ID: 17436021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of hepatic fibrosis through captopril and enalapril in the livers of bile duct ligated rats.
    Karimian G; Mohammadi-Karakani A; Sotoudeh M; Ghazi-Khansari M; Ghobadi G; Shakiba B
    Biomed Pharmacother; 2008 Jun; 62(5):312-6. PubMed ID: 18191530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study on the protective effects of Yinchenhao Decoction against liver injury induced by alpha-naphthylisothiocyanate and carbon tetrachloride.
    Cao HX; Sun H; Jiang XG; Lu HT; Zhang GM; Wang XJ; Sun WJ; Wu ZM; Wang P; Liu L; Zhou J
    Chin J Integr Med; 2009 Jun; 15(3):204-9. PubMed ID: 19568713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candesartan, rather than losartan, improves motor dysfunction in thioacetamide-induced chronic liver failure in rats.
    Murad HA; Gazzaz ZJ; Ali SS; Ibraheem MS
    Braz J Med Biol Res; 2017 Sep; 50(11):e6665. PubMed ID: 28953991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. V1/V2 Vasopressin receptor antagonism potentiates the renoprotection of renin-angiotensin system inhibition in rats with renal mass reduction.
    Perico N; Zoja C; Corna D; Rottoli D; Gaspari F; Haskell L; Remuzzi G
    Kidney Int; 2009 Nov; 76(9):960-7. PubMed ID: 19625993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of combination therapy with enalapril and losartan on the rate of progression of renal injury in rats with 5/6 renal mass ablation.
    Ots M; Mackenzie HS; Troy JL; Rennke HG; Brenner BM
    J Am Soc Nephrol; 1998 Feb; 9(2):224-30. PubMed ID: 9527398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ameliorative effect of Grewia tenax (Forssk) fiori fruit extract on CCl(4)-induced oxidative stress and hepatotoxicity in rats.
    Al-Said MS; Mothana RA; Al-Sohaibani MO; Rafatullah S
    J Food Sci; 2011; 76(9):T200-6. PubMed ID: 22416728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of ACE-I and AT-1 receptor blocker on the progression of CCl(4)-inducing rat hepatic fibrogenesis].
    Li X; Meng Y; Zhang ZS; Yang XS; Wu PS
    Zhonghua Yi Xue Za Zhi; 2003 Jul; 83(14):1241-5. PubMed ID: 12930639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.